Annual CFI
-$28.73 M
-$3.00 M-11.67%
June 30, 2024
Summary
- As of February 7, 2025, BIOX annual cash flow from investing activities is -$28.73 million, with the most recent change of -$3.00 million (-11.67%) on June 30, 2024.
- During the last 3 years, BIOX annual CFI has fallen by -$20.42 million (-245.70%).
- BIOX annual CFI is now -1089.57% below its all-time high of $2.90 million, reached on June 30, 2022.
Performance
BIOX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$271.80 K
+$566.90 K+192.10%
September 1, 2024
Summary
- As of February 7, 2025, BIOX quarterly cash flow from investing activities is $271.80 thousand, with the most recent change of +$566.90 thousand (+192.10%) on September 1, 2024.
- Over the past year, BIOX quarterly CFI has increased by +$8.96 million (+103.13%).
- BIOX quarterly CFI is now -98.25% below its all-time high of $15.51 million, reached on June 30, 2021.
Performance
BIOX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$19.77 M
+$8.96 M+31.18%
September 1, 2024
Summary
- As of February 7, 2025, BIOX TTM cash flow from investing activities is -$19.77 million, with the most recent change of +$8.96 million (+31.18%) on September 1, 2024.
- Over the past year, BIOX TTM CFI has increased by +$17.67 million (+47.19%).
- BIOX TTM CFI is now -199.87% below its all-time high of $19.79 million, reached on March 31, 2022.
Performance
BIOX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BIOX Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -11.7% | +103.1% | +47.2% |
3 y3 years | -245.7% | -91.0% | -628.3% |
5 y5 years | -781.0% | -91.0% | -628.3% |
BIOX Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -1089.6% | at low | -91.0% | +101.2% | -199.9% | +47.2% |
5 y | 5-year | -1089.6% | at low | -98.3% | +101.2% | -199.9% | +47.2% |
alltime | all time | -1089.6% | +75.3% | -98.3% | +100.2% | -199.9% | +83.0% |
Bioceres Crop Solutions Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $271.80 K(-192.1%) | -$19.77 M(-31.2%) |
Jun 2024 | -$28.73 M(+11.7%) | -$295.10 K(-78.5%) | -$28.73 M(-9.3%) |
Mar 2024 | - | -$1.37 M(-92.5%) | -$31.68 M(-5.6%) |
Dec 2023 | - | -$18.38 M(+111.5%) | -$33.57 M(-10.3%) |
Sep 2023 | - | -$8.69 M(+168.0%) | -$37.44 M(+45.5%) |
Jun 2023 | -$25.73 M(-986.1%) | -$3.24 M(-0.6%) | -$25.73 M(+7.8%) |
Mar 2023 | - | -$3.26 M(-85.3%) | -$23.87 M(+17.7%) |
Dec 2022 | - | -$22.25 M(-835.3%) | -$20.28 M(-642.0%) |
Sep 2022 | - | $3.03 M(-318.9%) | $3.74 M(+28.9%) |
Jun 2022 | $2.90 M(-134.9%) | -$1.38 M(-533.9%) | $2.90 M(-85.3%) |
Mar 2022 | - | $318.60 K(-82.1%) | $19.79 M(+152.1%) |
Dec 2021 | - | $1.78 M(-18.6%) | $7.85 M(-338.8%) |
Sep 2021 | - | $2.19 M(-85.9%) | -$3.29 M(-60.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2021 | -$8.31 M(+6.5%) | $15.51 M(-233.4%) | -$8.31 M(-71.6%) |
Mar 2021 | - | -$11.62 M(+24.2%) | -$29.25 M(+58.9%) |
Dec 2020 | - | -$9.36 M(+230.1%) | -$18.41 M(+89.1%) |
Sep 2020 | - | -$2.84 M(-47.8%) | -$9.73 M(+24.7%) |
Jun 2020 | -$7.80 M(+139.3%) | -$5.43 M(+593.8%) | -$7.80 M(+228.6%) |
Mar 2020 | - | -$782.40 K(+14.2%) | -$2.38 M(+49.1%) |
Dec 2019 | - | -$684.90 K(-24.5%) | -$1.59 M(+75.5%) |
Sep 2019 | - | -$907.70 K(<-9900.0%) | -$907.70 K(-99.2%) |
Jun 2019 | -$3.26 M(-97.2%) | - | - |
Jan 2019 | -$116.15 M(+1313.1%) | $0.00(0.0%) | -$116.15 M(0.0%) |
Oct 2018 | - | $0.00(0.0%) | -$116.15 M(0.0%) |
Jul 2018 | - | $0.00(-100.0%) | -$116.15 M(0.0%) |
Jun 2018 | -$8.22 M | - | - |
Apr 2018 | - | -$116.15 M | -$116.15 M |
FAQ
- What is Bioceres Crop Solutions annual cash flow from investing activities?
- What is the all time high annual CFI for Bioceres Crop Solutions?
- What is Bioceres Crop Solutions annual CFI year-on-year change?
- What is Bioceres Crop Solutions quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Bioceres Crop Solutions?
- What is Bioceres Crop Solutions quarterly CFI year-on-year change?
- What is Bioceres Crop Solutions TTM cash flow from investing activities?
- What is the all time high TTM CFI for Bioceres Crop Solutions?
- What is Bioceres Crop Solutions TTM CFI year-on-year change?
What is Bioceres Crop Solutions annual cash flow from investing activities?
The current annual CFI of BIOX is -$28.73 M
What is the all time high annual CFI for Bioceres Crop Solutions?
Bioceres Crop Solutions all-time high annual cash flow from investing activities is $2.90 M
What is Bioceres Crop Solutions annual CFI year-on-year change?
Over the past year, BIOX annual cash flow from investing activities has changed by -$3.00 M (-11.67%)
What is Bioceres Crop Solutions quarterly cash flow from investing activities?
The current quarterly CFI of BIOX is $271.80 K
What is the all time high quarterly CFI for Bioceres Crop Solutions?
Bioceres Crop Solutions all-time high quarterly cash flow from investing activities is $15.51 M
What is Bioceres Crop Solutions quarterly CFI year-on-year change?
Over the past year, BIOX quarterly cash flow from investing activities has changed by +$8.96 M (+103.13%)
What is Bioceres Crop Solutions TTM cash flow from investing activities?
The current TTM CFI of BIOX is -$19.77 M
What is the all time high TTM CFI for Bioceres Crop Solutions?
Bioceres Crop Solutions all-time high TTM cash flow from investing activities is $19.79 M
What is Bioceres Crop Solutions TTM CFI year-on-year change?
Over the past year, BIOX TTM cash flow from investing activities has changed by +$17.67 M (+47.19%)